Inventor · disambiguated record
William F. Degrado
Also filed as: DEGRADO WILLIAM · DEGRADO WILLIAM F · DEGRADO WILLIAM FRANK
42 granted patents·14 pending applications·540 citations·filing 1994–2022
98Inventor score
Files withDEGRADO WILLIAM F17UNIV CALIFORNIA14UNIV PENNSYLVANIA11DU PONT MERCK PHARMA8DU PONT PHARM CO4
Top patents by PatentIndex Score
56 records- 0195US8455490B2Facially amphiphilic polymers and oligomers and uses thereofDEGRADO WILLIAM F·Filed 2012·Granted Jun 4, 2013·13 cites·19 claims
- 0295US8236800B2Facially amphiphilic polymers and oligomers and uses thereofDEGRADO WILLIAM F·Filed 2007·Granted Aug 7, 2012·25 cites·14 claims
- 0393US10131658B2Anti-alphavbeta1 integrin compounds and methodsUNIV CALIFORNIA·Filed 2016·Granted Nov 20, 2018·15 cites·18 claims
- 0493US8278309B2Synthetic mimetics of host defense and uses thereofDEGRADO WILLIAM F·Filed 2009·Granted Oct 2, 2012·16 cites·12 claims
- 0590US8975262B2Synthetic mimetics of host defense and uses thereofDEGRADO WILLIAM F·Filed 2012·Granted Mar 10, 2015·10 cites·2 claims
- 0690US6022523ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT PHARM CO·Filed 1997·Granted Feb 8, 2000·46 cites·1 claims
- 0789US10214522B2Anti-alphavbeta1 integrin inhibitors and methods of useUNIV CALIFORNIA·Filed 2016·Granted Feb 26, 2019·15 cites·19 claims
- 0887US7173102B2Facially amphiphilic polymers as anti-infective agentsUNIV PENNSYLVANIA·Filed 2002·Granted Feb 6, 2007·34 cites·45 claims
- 0986US5849736AIsoxazoline and isoxazole fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 15, 1998·70 cites·31 claims
- 1085US8569284B2Inhibitors of the influenza A virus M2 proton channelDEGRADO WILLIAM F·Filed 2010·Granted Oct 29, 2013·3 cites·8 claims
- 1185US7910609B2Inhibitors of integrin alpha2beta1 with modified urea moietyUNIV PENNSYLVANIA·Filed 2008·Granted Mar 22, 2011·11 cites·34 claims
- 1285US5563158AAromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1994·Granted Oct 8, 1996·26 cites·22 claims
- 1384US8222456B2Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereofDEGRADO WILLIAM F·Filed 2005·Granted Jul 17, 2012·7 cites·30 claims
- 1481US8557836B2Spiro-piperidine inhibitorsDEGRADO WILLIAM F·Filed 2009·Granted Oct 15, 2013·3 cites·8 claims
- 1581US5703092AHydroxamic acid compounds as metalloprotease and TNF inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Dec 30, 1997·58 cites·11 claims
- 1680US9301950B2Adamantane analogsDEGRADO WILLIAM F·Filed 2010·Granted Apr 5, 2016·2 cites·14 claims
- 1780US8258159B2Inhibitors of the α2β1/GPIa-IIa integrinDEGRADO WILLIAM F·Filed 2006·Granted Sep 4, 2012·5 cites·33 claims
- 1880US7590517B2Methods, systems, and computer program products for computational analysis and design of amphiphilic polymersUNIV PENNSYLVANIA·Filed 2003·Granted Sep 15, 2009·30 cites·11 claims
- 1979US8716530B2Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereofDEGRADO WILLIAM F·Filed 2012·Granted May 6, 2014·4 cites·26 claims
- 2077US10836720B2Inhibitors of integrin alpha 5 beta 1 and methods of useUNIV CALIFORNIA·Filed 2017·Granted Nov 17, 2020·2 cites·21 claims
- 2176US8349791B2Polypeptides that bind membrane proteinsUNIV PENNSYLVANIA·Filed 2007·Granted Jan 8, 2013·3 cites·13 claims
- 2274US6677431B2Design, preparation, and properties of antibacterial β-peptidesUNIV PENNSYLVANIA·Filed 2000·Granted Jan 13, 2004·9 cites·20 claims
- 2371US6114328AIsoxazoline and isoxazole fibrogen receptor antagonistsDU PONT PHARM CO·Filed 1997·Granted Sep 5, 2000·27 cites·49 claims
- 2471US5691329ACompounds containing basic and acidic termini useful as fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1996·Granted Nov 25, 1997·13 cites·10 claims
- 2568US9453005B2Inhibition of influenza M2 proton channelDEGRADO WILLIAM F·Filed 2009·Granted Sep 27, 2016·0 cites·1 claims
- 2666US5773411ACyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIB/IIIADU PONT MERCK PHARMA·Filed 1994·Granted Jun 30, 1998·17 cites·12 claims
- 2765US9464075B2Influenza A virus inhibitionDEGRADO WILLIAM F·Filed 2009·Granted Oct 11, 2016·0 cites·4 claims
- 2865US2016151314A1Facially Amphiphilic Polymers and Oligomers and Uses ThereofUNIV PENNSYLVANIA·Filed 2015·Application pending·0 cites
- 2964US9241917B2Facially amphiphilic polymers and oligomers and uses thereofDEGRADO WILLIAM F·Filed 2004·Granted Jan 26, 2016·0 cites·44 claims
- 3064US5635477ACyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIADU PONT MERCK PHARMA·Filed 1995·Granted Jun 3, 1997·29 cites·22 claims
- 3163US9403777B2Inhibitors of the influenza A virus M2 proton channelUNIV PENNSYLVANIA·Filed 2013·Granted Aug 2, 2016·0 cites·10 claims
- 3262US2011236881A1Modulation of influenza virusDEGRADO WILLIAM F·Filed 2009·Application pending·0 cites
- 3362US2021231672A1Protein interactor detection systemsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3460US5849693ACyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIaDU PONT MERCK PHARMA·Filed 1997·Granted Dec 15, 1998·14 cites·18 claims
- 3560US2024409527A1Inhibitors of alpha-5 beta-1 integrin and uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3659US5879657ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT MERCK PHARMA·Filed 1994·Granted Mar 9, 1999·23 cites·70 claims
- 3759US2025145598A1Acid ceramidase inhibitors and uses thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3858US2023253066A1Designed proteins for ligand bindingUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3956US8987306B2Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffoldDEGRADO WILLIAM F·Filed 2009·Granted Mar 24, 2015·0 cites·24 claims
- 4054US2004215400A1Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsAUNIV PENNSYLVANIA·Filed 2004·Application pending·0 cites
- 4153US11643388B2Inhibitors of alpha 2 beta 1 integrin and methods of use thereofUNIV CALIFORNIA·Filed 2021·Granted May 9, 2023·0 cites·20 claims
- 4253US2013190254A1Polypeptides that bind membrane proteinsUNIV PENNSYLVANIA·Filed 2012·Application pending·0 cites
- 4352US11530180B2Alpha-5 beta-1 inhibitorsUNIV CALIFORNIA·Filed 2020·Granted Dec 20, 2022·0 cites·21 claims
- 4451US12493045B2Multi-target crosslinkers and uses thereofUNIV CALIFORNIA·Filed 2019·Granted Dec 9, 2025·0 cites·30 claims
- 4551US2019025316A1Protein interactor detection systemsUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 4650US6281352B1Macrocyclic compounds as metalloprotease inhibitorsDU PONT PHARM CO·Filed 1997·Granted Aug 28, 2001·10 cites·50 claims
- 4749US2016003843A1Engineered antibody scaffoldsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 4847US8476037B2Method for screening of antiviral agentsINOUYE MASAYORI·Filed 2011·Granted Jul 2, 2013·0 cites·2 claims
- 4946US11597727B2Inhibitors of integrin alpha 2 beta 1 and methods of useUNIV CALIFORNIA·Filed 2019·Granted Mar 7, 2023·0 cites·27 claims
- 5046US9884832B2Inhibitors targeting drug-resistant influenza AUNIV PENNSYLVANIA·Filed 2012·Granted Feb 6, 2018·0 cites·1 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William F. Degrado files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →